MIR-29c in urinary exosomes as predictor of early renal fibrosis in lupus nephritis

Nephrology Dialysis Transplantation

Volumn 30, Issue 9, 2015, Pages 1488-1496

  Sole, Cristina ^a   Cortes Hernandez, Josefina ^a   Felip, Maria L ^a,b   Vidal, Marta ^b   Ordi Ros, Josep ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

Biomarker; lupus nephritis; microRNA; renal fibrosis; urinary exosome

Indexed keywords

BIOLOGICAL MARKER; CREATININE; GELATINASE A; GELATINASE B; MICRORNA 29; MICRORNA 29C; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; MESSENGER RNA; MICRORNA; MIRN29 MICRORNA, HUMAN; MMP2 PROTEIN, HUMAN; SMAD3 PROTEIN, HUMAN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; FEMALE; GENE EXPRESSION REGULATION; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY FIBROSIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; UPREGULATION; WESTERN BLOTTING; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; COMPLICATION; FIBROSIS; GENETICS; METABOLISM; PATHOLOGY; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; URINE;

ADULT; AREA UNDER CURVE; BIOMARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXOSOMES; FEMALE; FIBROSIS; HUMANS; KIDNEY FAILURE, CHRONIC; LUPUS NEPHRITIS; MALE; MATRIX METALLOPROTEINASE 2; MICRORNAS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMAD3 PROTEIN;

EID: 84940703386     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv128     Document Type: Article

References (33)

1. Maroz N, Segal MS. Lupus nephritis and end-stage kidney disease. Am J Med Sci 2013; 346: 319-323
2. Nowling TK, Gilkeson GS. Mechanisms of tissue injury in lupus nephritis. Arthritis Res Ther 2011; 13: 250
3. Bohle A, Mackensen-Haen S, Von Gise H. Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution. Am J Nephrol 1987; 7: 421-433
4. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007; 117: 524-529
5. Lorenzen JM, Haller H, Thum T. MicroRNAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol 2011; 7: 286-294
6. Chung ACK, Yu X, Lan HY. MicroRNA and nephropathy: emerging concepts. Int J Nephrol Renovasc Dis 2013; 6: 169-179
7. Bottinger EP. TGF-beta in renal injury and disease. Semin Nephrol 2007; 27: 309-320
8. Massague J, Chen YG. Controlling TGF-beta signaling. Genes Dev 2000; 14: 627-644
9. Meng XM, Chung AC, Lan HY. Role of the TGF-/BMP-7/Smad pathways in renal diseases. Clin Sci 2013; 124: 243-254
10. Chung AC, Huang XR, Meng X et al. miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J Am Soc Nephrol 2010; 21: 1317-1325
11. Zarjou A, Yang S, Abraham E et al. IDentification of a microRNA signature in renal fibrosis: role of miR-21. Am J Physiol Renal Physiol 2011; 301: F793-F801
12. Qin W, Chung AC, Huang XR et al. TGF-/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 2011; 22: 1462-1474
13. Xiong M, Jiang L, Zhou Y et al. The miR-200 family regulates TGF-1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol 2012; 302: F369-F379
14. Wang B, Komers R, Carew R et al. Suppression of microRNA-29 expression by TGF-1 promotes collagen expression and renal fibrosis. J Am Soc Nephrol 2012; 23: 252-265
15. Lv LL, Cao YH, Ni HF et al. MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis. Am J Physiol Renal Physiol 2013; 305: F1220-7
16. Dai Y, SuiW, LanHet al. Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. Rheumatol Int 2009; 29: 749-754
17. Lu J, Kwan BC, Lai FM et al. Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton) 2012; 17: 346-351
18. Zhou H, Hasni SA, Perez P et al. MiR-150 promotes renal fibrosis in LN by downregulating SOCS1. J Am Soc Nephrol 2013; 24: 1073-1087
19. MiranDa KC, Bond DT, McKee M et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int 2010; 78: 191-199
20. Pisitkun T, Shen RF, Knepper MA. IDentification and proteomic profiling of exosomes in human urine. Proc Natl Acad Sci USA 2004; 101: 13368-13373
21. Hoorn EJ, Pisitkun T, Zietse R et al. Prospects for urinary proteomics: exosomes as a source of urinary biomarkers. Nephrology (Carlton) 2005; 10: 283-290
22. Barutta F, Tricarico M, Corbelli A et al. Urinary exosomal microRNAs in incipient diabetic nephropaty. PLoS One 2013; 8: e73798
23. Bala S, PetraseK J, Mundkur S et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, grug-induced, and inflammatory liver disease. Hepatology 2012; 56: 1946-1957
24. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-Derived exosomes as diagnostic biomarkers of ovarian cancer. Gymnecol Oncol 2008; 110: 13-21
25. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
26. Weening JJ, D'Agati VD, Schwartz MM et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-250
27. Austin HA, 3rd, Muenz LR, Joyce KM et al. Prognostic factors in lupus nephritis. Contribution of renal histologic Data. Am J Med 1983; 75: 382-391
28. Alvarez ML, KhosroheiDari M, Ravi RK et al. Comparison of protein, microRNA, and mRNA yields using different methods of urinary exosome isolation for the discovery of kidney disease biomarkers. Kidney Int 2012; 82: 1024-1032
29. Simpson RJ, Lim JW, Moritz RL et al. Exosome: proteomic insights and diagnostic potential. Expert. Rev. Proteomics 2009; 6: 267-283
30. Lv LL, Cao YH, Pan MM et al. CD2AP mRNA in urinary exosome as biomarker of kidney disease. Clin Chim Acta 2014; 428: 26-31
31. Fang Y, Yu X, Liu Y et al. MiR-29c is downregulated in renal interstitial fibrosis in humans and rats and restored by HIF-activation. Am J Physiol Renal Physiol 2013; 304: F1274-F1282
32. Long J, Wang Y, Wang W et al. MicroRNA-29c is a signature microRNA unDer high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy. J Biol Chem 2011; 286: 11837-11848
33. Spanu S, Van Roeyen CR, Denecke B et al. Urinary exosomes: a novel means to non-invasively assess changes in renal gene and protein expression. PLoS One 2014; 9: e109631